Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Polar Capital Holdings Plc

Polar Capital Holdings Plc lessened its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 3.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,250,000 shares of the financial services provider’s stock after selling 50,000 shares during the period. Polar Capital Holdings Plc’s holdings in Trupanion were worth $60,250,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Trupanion by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock valued at $173,362,000 after buying an additional 45,653 shares during the period. Marshall Wace LLP lifted its holdings in Trupanion by 6.9% in the 4th quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock valued at $43,459,000 after acquiring an additional 57,804 shares during the last quarter. Balyasny Asset Management L.P. boosted its position in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after purchasing an additional 661,559 shares in the last quarter. Baillie Gifford & Co. grew its stake in shares of Trupanion by 26.6% in the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after purchasing an additional 147,341 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of Trupanion by 9.0% in the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider’s stock worth $17,749,000 after purchasing an additional 30,549 shares during the last quarter.

Trupanion Stock Performance

TRUP opened at $45.73 on Thursday. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The stock’s 50 day moving average price is $37.43 and its two-hundred day moving average price is $44.45. The firm has a market capitalization of $1.96 billion, a P/E ratio of -198.83, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. The business had revenue of $341.98 million during the quarter, compared to analysts’ expectations of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm’s revenue was up 11.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.16) earnings per share. On average, equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In related news, insider Brenna Mcgibney sold 5,000 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $164,950.00. Following the completion of the sale, the insider now directly owns 3,738 shares of the company’s stock, valued at $123,316.62. This trade represents a 57.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Emily Dreyer sold 14,025 shares of Trupanion stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now directly owns 27,645 shares of the company’s stock, valued at $895,974.45. This represents a 33.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,792 shares of company stock valued at $1,122,802. 5.50% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on TRUP shares. Piper Sandler cut their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Stifel Nicolaus cut their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Finally, Lake Street Capital reduced their price objective on Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $51.80.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.